Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1

Status

Terminated 3 Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Medulloblastoma 1

Interventions

pembrolizumab 219 Carboplatin 218 Specimen Handling 198 Cisplatin 188 Magnetic Resonance Spectroscopy 168 Radiotherapy 152 Bevacizumab 142 Gemcitabine 135 Cyclophosphamide 133 Drug Therapy 118 Capecitabine 118 Paclitaxel 112 Oxaliplatin 110 Biopsy 107 venetoclax 102 Nivolumab 101 Rituximab 83 tislelizumab 81 durvalumab 81 toripalimab 77 Fluorouracil 73 Etoposide 72 Dexamethasone 70 sintilimab 67 Radiosurgery 67 Docetaxel 67 Pemetrexed 65 atezolizumab 64 Azacitidine 63 Injections 62

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Recruiting × Digoxin × Clear all

NCT06701812 2026-02-27

Digoxin Medulloblastoma Study

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡